Results 21 to 30 of about 61,892 (248)

Insulin edema after initiation of hybrid closed-loop insulin pump therapy with continuous glucose monitoring: a case report

open access: yesClinical Diabetes and Endocrinology, 2022
Background Insulin edema is a rare complication which can present after initiation or intensification of insulin therapy in people with diabetes. Initiation of closed-loop hybrid insulin pump therapy can result in rapid improvement in glycemic control ...
Mostafa Vasigh, Rachel Hopkins
doaj   +1 more source

Leeno: Type 1 diabetes management training environment using smart algorithms

open access: yesPLoS ONE, 2022
A growing number of Type-1 Diabetes (T1D) patients globally use insulin pump technologies to monitor and manage their glucose levels. Although recent advances in closed-loop systems promise automated pump control in the near future, most patients ...
Mohamed Raef Smaoui, Ahmad Lafi
doaj   +2 more sources

Assessment of Patients Knowledge and Attitude Regarding Insulin Pump Therapy [PDF]

open access: yesHelwan International Journal for Nursing Research and Practice
Background: Assessing patients' knowledge and attitude regarding insulin pump therapy is crucial for ensuring the effective management of diabetes. A well-informed patient is more likely to properly adhere to the therapy, which can lead to better blood ...
Samar Mohamed
doaj   +1 more source

Perioperative glycemic control in patients with coronary artery disease and diabetes mellitus type 2 undergoing coronary artery bypass grafting: results of pilot study

open access: yesСахарный диабет, 2020
BACKGROUND: According to different studies, diabetes mellitus type 2 (DM2) is associated with higher mortality after undergoing coronary artery bypass grafting (CABG).
Elena Z. Golukhova   +3 more
doaj   +1 more source

Dermatological Complications of Insulin Therapy in Children with Type 1 Diabetes: Cross-Sectional Study

open access: yesВопросы современной педиатрии, 2020
Background. Dermatological complications of insulin therapy in children with type 1 diabetes (T1D) cause low patient retention to treatment, reduce insulin therapy (with injection pens and pumps) efficiency, limit the use of modern high-tech methods of ...
Alisa V. Vitebskaya   +2 more
doaj   +1 more source

Insulin pump therapy in transient neonatal diabetes mellitus [PDF]

open access: yesAnnals of Pediatric Endocrinology & Metabolism, 2013
Neonatal diabetes mellitus (NDM) is a rare disease requiring insulin treatment. Its treatment is primarily focused on maintaining adequate glycemic control and avoiding hypoglycemia.
Joong Heum Park   +6 more
doaj   +1 more source

Prevalence of 21 Physician‐Defined Severe Toxicities Following Childhood Acute Lymphoblastic Leukemia Treatment: Australian Retrospective Cohort Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with an overall survival now surpassing 90% in developed countries. However, treatments are not without adverse effects. In this study, we apply the severe toxicity‐free survival (STFS) framework to determine the prevalence of 21 physician‐defined severe ...
Lane Collier   +10 more
wiley   +1 more source

Misperception of Body Weight After Childhood Cancer

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Misperception of body weight can negatively impact the weight management efforts of childhood cancer survivors (CCSs). Both being overweight or underweight are associated with chronic health conditions commonly observed in CCS; therefore, accurate weight perception is critical for reducing long‐term health risks.
Fabiën N. Belle   +8 more
wiley   +1 more source

Insulin Pumps [PDF]

open access: yesDiabetes Technology & Therapeutics, 2020
Lal, Rayhan, Leelarathna, Lalantha
openaire   +3 more sources

Long-term glycemic control and factors, associated with response to pump insulin therapy in children

open access: yesСахарный диабет, 2021
Background: In recent years, pump-based insulin therapy, also known as continuous subcutaneous insulin infusion (CSII), has become a common treatment for children with type 1 diabetes mellitus (T1DM). Despite the fact that, in general, children with type
D. N. Laptev   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy